Search

Qin, Liuliang, Dezheng Zhao, Jianfeng Xu, Xianghui Ren, Ernest F Terwilliger, Sareh Parangi, Jack Lawler, Harold F Dvorak, and Huiyan Zeng. 2013. “The Vascular Permeabilizing Factors Histamine and Serotonin Induce Angiogenesis through TR3/Nur77 and Subsequently Truncate It through Thrombospondin-1.”. Blood 121 (11): 2154-64.

Lynch, Jeffrey M, Marjorie Maillet, Davy Vanhoutte, Aryn Schloemer, Michelle A Sargent, Scott Blair, Kaari A Lynch, et al. 2012. “A Thrombospondin-Dependent Pathway for a Protective ER Stress Response.”. Cell 149 (6): 1257-68.

Lawler, Patrick R, and Jack Lawler. 2012. “Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2.”. Cold Spring Harbor Perspectives in Medicine 2 (5): a006627.

Adams, Josephine C, and Jack Lawler. 2011. “The Thrombospondins.”. Cold Spring Harbor Perspectives in Biology 3 (10): a009712.

Nucera, Carmelo, Matthew A Nehs, Sushruta S Nagarkatti, Peter M Sadow, Michal Mekel, Andrew H Fischer, Paul S Lin, et al. 2011. “Targeting BRAFV600E With PLX4720 Displays Potent Antimigratory and Anti-Invasive Activity in Preclinical Models of Human Thyroid Cancer.”. The Oncologist 16 (3): 296-309.

Nucera, Carmelo, Jack Lawler, Richard Hodin, and Sareh Parangi. 2010. “The BRAFV600E Mutation: What Is It Really Orchestrating in Thyroid Cancer?”. Oncotarget 1 (8): 751-6.

Lawler, Jack, and Michael Detmar. 2004. “Tumor Progression: The Effects of Thrombospondin-1 and -2.”. The International Journal of Biochemistry & Cell Biology 36 (6): 1038-45.

Cursiefen, Claus, Sharmila Masli, Tat Fong Ng, Reza Dana, Paul Bornstein, Jack Lawler, and Wayne Streilein. 2004. “Roles of Thrombospondin-1 and -2 in Regulating Corneal and Iris Angiogenesis.”. Investigative Ophthalmology & Visual Science 45 (4): 1117-24.

Hamano, Yuki, Hikaru Sugimoto, Mary A Soubasakos, Mark Kieran, Bjorn R Olsen, Jack Lawler, Akulapalli Sudhakar, and Raghu Kalluri. 2004. “Thrombospondin-1 Associated With Tumor Microenvironment Contributes to Low-Dose Cyclophosphamide-Mediated Endothelial Cell Apoptosis and Tumor Growth Suppression.”. Cancer Research 64 (5): 1570-4.

Bocci, Guido, Giulio Francia, Shan Man, Jack Lawler, and Robert S Kerbel. 2003. “Thrombospondin 1, a Mediator of the Antiangiogenic Effects of Low-Dose Metronomic Chemotherapy.”. Proceedings of the National Academy of Sciences of the United States of America 100 (22): 12917-22.